KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/76834
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rani S | en_US |
dc.contributor.author | Madhumitha B | en_US |
dc.contributor.author | Beelagi MS | en_US |
dc.contributor.author | Uma Bharathi I | en_US |
dc.contributor.author | Mamathashree MN | en_US |
dc.contributor.author | Chandrashekar S | en_US |
dc.contributor.author | Kumar SK | en_US |
dc.contributor.author | Hemadri D | en_US |
dc.contributor.author | Patil SS | en_US |
dc.contributor.author | Suresh KP | en_US |
dc.date.accessioned | 2023-04-12T07:26:01Z | - |
dc.date.available | 2023-04-12T07:26:01Z | - |
dc.date.issued | 2022-11-24 | - |
dc.identifier.citation | 13. Rani S, Madhumitha B, Beelagi MS, Uma Bharathi I, Mamathashree MN, Chandrashekar S, Kumar SK, Hemadri D, Patil SS and Suresh KP. (2022). Unveiling Acacia farnesiana phytochemicals as Angiotensin Converting Enzyme (ACE) inhibitors via in-silico drug design, molecular docking, and bioavailability predictions: An illustration against SARS-CoV-2 spike protein. Journal of Ayurveda and Herbal Medicine, 8(4): 209-220. | en_US |
dc.identifier.issn | 2454-5023 | - |
dc.identifier.uri | http://krishi.icar.gov.in/jspui/handle/123456789/76834 | - |
dc.description | Not Available | en_US |
dc.description.abstract | Angiotensin-converting enzyme 2 (ACE2) is a transmembrane protein that functions as a receptor for coronavirus spike protein. When spike protein fragments as the ligand binds with ACE2 protein, this ACE2 protein functions as a virus receptor, participating in the biological process known as the viral particle entry in the host cell. Hence, an in-silico study was carried out since it is faster and less expensive than trial and error methods based on experimental investigations. To study the effect of Acacia farnesiana phytochemicals on spike protein, molecular docking analyses were carried out. In this study, twelve phytochemicals from Acacia farnesiana have been selected as small molecules based on their ACEI and anti- inflammatory nature to evaluate molecular interaction between spike protein of SARSCoV2 with ACE2 of the human complex molecule. Gallic acid, methyl gallate, kaempferol, Rhamnocitrin, naringenin, apigenin, ellagic acid, ferulic acid, myricetin, Diosmetin, Caffeic acid, and Quercetin were chosen as competent natural compounds from Acacia farnesiana as potent small molecules against COVID-19 and further ADME analysis were carried out. The result indicated that due to the presence of ACEIs and anti-inflammatory phytochemicals in Acacia farnesiana, the bound structure of ACE2 and spike protein becomes unstable. Therefore, these natural compounds can show antiviral activity by destabilizing spike protein binding with the human host ACE2 receptor. | en_US |
dc.description.sponsorship | Not Available | en_US |
dc.language.iso | English | en_US |
dc.publisher | BioMed Research Publishers | en_US |
dc.relation.ispartofseries | Not Available; | - |
dc.subject | Acacia farnesiana | en_US |
dc.subject | ACE2 | en_US |
dc.subject | Molecular docking | en_US |
dc.subject | Phytochemicals | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.title | Unveiling Acacia farnesiana phytochemicals as Angiotensin Converting Enzyme (ACE) inhibitors via in-silico drug design, molecular docking, and bioavailability predictions: An illustration against SARS-CoV-2 spike protein. | en_US |
dc.title.alternative | Not Available | en_US |
dc.type | Research Paper | en_US |
dc.publication.projectcode | Not Available | en_US |
dc.publication.journalname | Journal of Ayurvedic and Herbal Medicine | en_US |
dc.publication.volumeno | 8 | en_US |
dc.publication.pagenumber | 209-220 | en_US |
dc.publication.divisionUnit | Not Available | en_US |
dc.publication.sourceUrl | 10.31254/jahm.2022.8401 | en_US |
dc.publication.authorAffiliation | Sri Krishna Arts and Science College, Coimbatore, Tamil Nadu- 641008, India | en_US |
dc.publication.authorAffiliation | National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Yelahanka, Bengaluru, | en_US |
dc.publication.authorAffiliation | Chanre Rheumatology and Immunology Centre and Research, Bengaluru, Karnataka- 560010, India | en_US |
dc.publication.authorAffiliation | The University of Trans-Disciplinary Health Sciences and Technology (TDU), Yelahanka, Bengaluru | en_US |
dc.ICARdataUseLicence | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf | en_US |
dc.publication.journaltype | Peer reviewed Journal | en_US |
dc.publication.naasrating | 4.16 | en_US |
dc.publication.impactfactor | Not listed in Journal Impact factor list | en_US |
Appears in Collections: | AS-NIVEDI-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.